Theresa Cerulli, MD

Articles by Theresa Cerulli, MD

Future ADHD Treatment Options

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

November 21st 2022

Experts in attention-deficit/hyperactivity disorder discuss future nonmedication interventions, like trigeminal nerve stimulation and digital therapeutics.

Adult ADHD Treatment: Serdexmethylphenidate/Dexmethylphenidate

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

November 21st 2022

Theresa Cerulli, MD, discusses the practical considerations for using serdexmethylphenidate-dexmethylphenidate for the treatment of attention-deficit/hyperactivity disorder.

FDA Approval: Serdexmethylphenidate/Dexmethylphenidate for Adult ADHD Treatment

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

November 14th 2022

Theresa Cerulli, MD, describes the indication and mechanism of the recent FDA approved combination product serdexmethylphenidate /dexmethylphenidate for the treatment of attention deficit/hyperactivity disorder (ADHD).

Adult ADHD Treatment Failure

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

November 14th 2022

Experts in attention-deficit/hyperactivity disorder (ADHD) discuss how to determine treatment failure in adults and the benefit of different dosing strategies for therapeutic options.

Adult ADHD: Substance Abuse Challenges

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

November 7th 2022

Theresa Cerulli, MD, and Anthony Rostain, MD, MA, discuss challenges with substance abuse related to pharmacologic interventions for adult attention-deficit/hyperactivity disorder (ADHD) treatment.

Adult ADHD Treatment: Access to Different Drug Formulations

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

November 7th 2022

Experts in treatment of attention-deficit/hyperactivity disorder discuss the benefits of different drug formulations and the potential for abuse of immediate-release medications.

Adult ADHD Treatment: Pharmacological Intervention

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

October 31st 2022

Anthony Rostain, MD, MA, provides an overview of stimulants, nonstimulants, amphetamines, and methylphenidates for adult attention-deficit/hyperactivity disorder (ADHD) treatment.

Treatment Goals and Shared Decision Making for Adults With ADHD

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

October 31st 2022

Experts in attention-deficit/hyperactivity disorder (ADHD) discuss the importance of patient education and shared decision-making in working toward treatment goals.

Novel Drug Delivery Systems in ADHD and Take-Home Messages

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 28th 2022

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss novel drug delivery systems and provide take-home messages when treating an adult with ADHD.

Implications of Pharmacogenetic Testing in ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 28th 2022

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss implications of pharmacogenetic testing in ADHD.

Signs and Symptoms of Adult ADHD

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

October 24th 2022

Anthony Rostain, MD, MA, describes some of the signs and symptoms of adult attention-deficit/hyperactivity disorder (ADHD), as well as the impact on psychosocial skills.

Recent Spikes in Adult ADHD Diagnoses

ByTheresa Cerulli, MD,Anthony L. Rostain, MD, MA

October 24th 2022

Theresa Cerulli, MD, and Anthony Rostain, MD, MA, discuss the recent spike of adult attention-deficit/hyperactivity disorder (ADHD) diagnoses and how this has been impacted by COVID-19 and telehealth.

Case 3: Factors Driving Treatment Selection in Adult ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 21st 2022

ADHD experts discuss factors that drive treatment selection when selecting therapy for an adult with ADHD.

Case 3: Treatment Goals in Adult ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 21st 2022

Theresa Cerulli, MD, and Andrew J. Cutler, MD, provide insight on goals of therapy for patients with ADHD.

Case 3: 24-Year-Old Patient With ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 21st 2022

Stephen Faraone, PhD, presents the case of a 24-year-old patient with ADHD.

Patient Case #2: Importance of an Integrative Approach in Adult ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 14th 2022

ADHD experts discuss the importance of an integrative approach in the treatment of adults with ADHD.

Patient Case #2: Addressing Non-Adherence and Stigma of Adult ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 14th 2022

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss addressing non-adherence and the stigma of ADHD.

Patient Case #2: Dealing With Comorbidities in Adult ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 7th 2022

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to deal with other comorbidities when treating an adult with ADHD.

Patient Case #2: Impressions and Challenges in Adult ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 7th 2022

Experts in psychiatry provide insight on a patient case as well as discuss challenges with ADHD.

Patient Case #2: A 23-Year-Old Patient With ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

October 7th 2022

Stephen Faraone, PhD, presents the case of a 23-year-old patient with ADHD.

Patient Case #1: Dealing With Treatment Delay in Adult ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

September 30th 2022

A panel of ADHD specialists discuss the impact of treatment delay when dealing with an adult patient.

Patient Case #1: Co-Managing ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

September 30th 2022

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to co-manage a patient with ADHD with other specialties.

Patient Case #1: Differentiating Between ADHD and Other Psychiatric Comorbidities

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

September 23rd 2022

Experts in psychiatry discuss tips to differentiate between ADHD and other co-morbid psychiatric disorders.

Patient Case #1: Prompting an ADHD Consultation

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

September 23rd 2022

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss factors which prompt adults for an ADHD consultation.

Patient Case #1: 19-Year-Old Male With ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

September 23rd 2022

Stephen Faraone, PhD, presents the case of a 19-year-old male with ADHD.

Future of Adult ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

September 16th 2022

Experts in psychiatry discuss the future of ADHD management as well as challenges when approaching treatment of adult ADHD.

Efficacy and Safety of Treatment Options Utilized in Adult ADHD

ByStephen V. Faraone, MD, PhD,Theresa Cerulli, MD,Craig Chepke, MD, DFAPA, FAPA,Andrew J. Cutler, MD

September 16th 2022

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss efficacy and safety of treatment options in adults with ADHD.